.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cerilliant
Cipla
Fuji
Novartis
Merck
Daiichi Sankyo
Moodys
Johnson and Johnson
Federal Trade Commission

Generated: February 17, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 102 15 067

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-001Jul 23, 2014DISCNYesNo➤ Sign Up➤ Sign UpY
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-002Jul 23, 2014DISCNYesNo➤ Sign Up➤ Sign UpY
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-003Jul 23, 2014DISCNYesNo➤ Sign Up➤ Sign UpY
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-001Jul 23, 2014DISCNYesNo➤ Sign Up➤ Sign UpY
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-002Jul 23, 2014DISCNYesNo➤ Sign Up➤ Sign UpY
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-003Jul 23, 2014DISCNYesNo➤ Sign Up➤ Sign UpY
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-001Jul 23, 2014DISCNYesNo➤ Sign Up➤ Sign UpYMANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE.
Purdue Pharma LpTARGINIQnaloxone hydrochloride; oxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL205777-002Jul 23, 2014DISCNYesNo➤ Sign Up➤ Sign UpYMANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE.
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist